US Patent 7998943 Core 2 GlcNAc-T inhibitors III
Patent 7998943 was granted and assigned to BTG International Limited on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+299 characters)
Article
Patent abstract
A method of treating a subject in need of therapy for a condition involving detrimental activity of the enzyme core 2 GlcNAc-T is provided, comprising administration of a therapeutically effective amount of an inhibitor of core 2 GlcNAc-T of the formula I to a patient in need thereof
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07998943 Core 2 GlcNAc-T inhibitors III US Patent 7998943 Core 2 GlcNAc-T inhibitors III
Infobox
Patent Number
0799894300
Patent Number
799894300
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079989430
Date of Patent
August 16, 2011
0Patent Application Number
114812560
Date Filed
July 6, 2006
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079989430
Date of Patent
August 16, 2011
0Patent Application Number
114812560
Date Filed
July 6, 2006
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07998943 Core 2 GlcNAc-T inhibitors III
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07998943
Date of patent
August 16, 2011
Patent application number
11481256
Date Filed
July 6, 2006
Patent primary examiner
Find more entities like US Patent 7998943 Core 2 GlcNAc-T inhibitors III
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
